-
effectivehealthcare.ahrq.gov/health-topics/encephalitis
-
effectivehealthcare.ahrq.gov/health-topics/amyotrophic-lateral-sclerosis
-
effectivehealthcare.ahrq.gov/health-topics/huntingtons-disease
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
December 01, 2024 - and surgical patients, and the other study, by Weller et al.,14 looked at
unexpected mortality in neurological … .35 The other studies found
no improvement in mortality, but one was in a restricted population of neurological … Evaluation of a wireless, portable, wearable
multi-parameter vital signs monitor in
hospitalized neurological
-
hcup-us.ahrq.gov/reports/methods/2020-04.pdf
January 01, 2020 - respiratory or circulatory disease, craniofacial anomalies,
neuromuscular disorders, or degenerative neurological … software, diabetes must be the
principal diagnosis and long-term complications include renal, eye,
neurological … respiratory or circulatory disease, craniofacial anomalies,
neuromuscular disorders, or degenerative neurological
-
psnet.ahrq.gov/web-mm/perioperative-anaphylaxis-after-insertion-latex-drain-patient-known-latex-allergy
July 08, 2022 - SPOTLIGHT CASE
Perioperative Anaphylaxis After Insertion of a Latex Drain in a Patient with Known Latex Allergy
Citation Text:
Kelly KJ. Perioperative Anaphylaxis After Insertion of a Latex Drain in a Patient with Known Latex Allergy. PSNet [internet]. Rockville (MD): Agency for Healthcare Resear…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
November 19, 2009 - Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations
Medical Tests—White Paper Series
Decision-Analytic Modeling to Evaluate
Benefits and Harms of Medical Tests—
Uses and Limitations
The findings and conclusions in thi…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/mhs-IV-epc-grand-rounds-slides.pptx
January 01, 2023 - AHRQ Slide Template 2019-Widescreen
AHRQ Evidence-based Practice Center Program
Grand Rounds Series
Making Healthcare Safer IV Reports
Welcome!
Logistics
This meeting will be recorded and shared externally.
Please use the chat for questions and feedback throughout the session or use the hand-raising functionality …
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
August 01, 2023 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication
August 01, 2023
Recommendations made by the USPSTF are in…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0129table8.pdf
January 01, 2013 - Table 8 – Evidence for the Relationship between Readmission and Quality of Care
Type of Evidence Key Findings Citation
Readmission and Quality of Care Coordination, Discharge, and Care
Transition Processes
Meta-analysis Investigators reviewed
randomized controlled
studies of structured
telephone support or
t…
-
www.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-test-result-communication-references.html
July 01, 2024 - Electronic Test Result Communication in the Era of the 21st Century Cures Act
References
Previous Page Next Page
Table of Contents
Electronic Test Result Communication in the Era of the 21st Century Cures Act
Introduction
Methods
Results
Discussion
Conclusions
References
Appendix A. Da…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
August 01, 2012 - the effectiveness of
FGAs and SGAs with patient subpopulations, including
patients with medical and neurological
-
hcup-us.ahrq.gov/db/nation/nis/NISvariables1988-2014forHCUP-US.pdf
October 14, 2016 - Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes CM_METS
CM_NEURO Severity AHRQ comorbidity measure: Other neurological
-
hcup-us.ahrq.gov/db/nation/nis/NISvariables1988-2012forHCUP-US.pdf
May 14, 2013 - Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes CM_METS
CM_NEURO Severity AHRQ comorbidity measure: Other neurological
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/ltvv-litreview.docx
January 01, 2017 - tended to be lower, and duration of intubation and duration of SICU stay tended to be shorter for non-neurological
-
www.ahrq.gov/hai/tools/mvp/modules/technical/ltvv-lit-review.html
January 01, 2017 - tended to be lower, and duration of intubation and duration of SICU stay tended to be shorter for non-neurological
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
January 01, 2012 - measure: Metastatic
cancer 7,296,968 0 0.00 1.00 0.02 0.13
CM_NEURO : AHRQ comorbidity measure: Other
neurological
-
www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/resources/issue-briefs/dxsafety-ehr-impact.pdf
August 01, 2024 - The accuracy of bedside neurological diagnoses.
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
January 01, 2014 - measure: Metastatic cancer 14,894,613 0 0.00 1.00 0.02 0.14
CM_NEURO : AHRQ comorbidity measure: Other neurological
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
October 31, 2017 - measure: Metastatic cancer 12,927,179 0 0.00 1.00 0.02 0.14
CM_NEURO : AHRQ comorbidity measure: Other neurological